Background: Behavioral variant frontotemporal dementia (bvFTD) is a relatively well-defined clinical syndrome. It is associated with frontal and temporal lobe structural/metabolic changes and pathologic findings of a neurodegenerative disease. We have been evaluating patients with clinical and imaging features partially consistent with bvFTD but with evidence also suggestive of brain sagging, which we refer to as frontotemporal brain sagging syndrome (FBSS).
sex, age at onset, presenting symptoms, mental status, laboratory and radiographic findings, and treatments and outcomes.
Standard protocol approvals, registrations, and patient consents. All patients consented to the use of their clinical records for the purpose of research. This study was approved by the Mayo institutional review board.
RESULTS Patient characteristics. We identified 8 patients (7 male) with FBSS. They presented to our institution at a median time of 11 months after symptom onset (range 6 -48 months). The presenting clinical characteristics are summarized in table 1.
All 8 patients were noted to have behavioral changes characterized by disinhibition and apathy. Onset was insidious and progressive at a median age of 53 years (range 45-59 years). Each patient had cognitive impairment, though behavioral disturbance was always more prominent. No patient was able to hold employment. Four (patients 1, 2, 4, and 7) were noted to be sexually inappropriate; patient 7 had legal charges for aggressive behavior.
Notably, all patients also had daytime somnolence that began concurrently with the behavior changes. Each patient had headache, with onset occurring either before or concurrently with the behavioral changes. Four patients reported an orthostatic component to their headache, but this was a significant feature in only one (patient 8).
In addition, some patients also had various symptoms suggestive of dysfunction of the deep midline structures, cerebellum, or brainstem, including dysarthria, dysphagia, unsteady gait, ocular abnormalities, and movement disorders; none had falls. Laboratory findings. Serum. Serum laboratory evaluations were unremarkable except as described. Patient 2 was noted to have an elevated thyroid peroxidase anti-body level of 44.6 IU/mL (normal Ͻ9.0 IU/mL). Patients 6 and 8 were noted to have elevated acetylcholine ganglionic neuronal antibodies values of 1.87 and 0.16 nmol/L, respectively (normal Յ0.02 nmol/L).
Of the 3 (patients 2, 4, and 5) who had genetic testing, no mutations in the microtubule-associated protein tau (MAPT) or progranulin (GRN) genes were detected.
CSF. The results of CSF examination are summarized in table e-1 on the Neurology ® Web site at www.neurology.org. The opening pressure varied widely, though only patient 8 had low pressure. The protein was mildly elevated, with normal glucose and cell counts.
Radiologic examination. Brain MRI. In each patient, a characteristic sagging appearance with brainstem swelling was noted (figure 1). The cerebellar tonsils were low-lying, but this was less marked compared to the sagging appearance. In addition, 4/8 (patients 3, 4, 6, and 8) were noted to have transtentorial herniation of the medial temporal lobe structures and corpus callosum. Pachymeningeal enhancement, subdural fluid collections, and atrophy were uncommon (table 2). With the exception of resolving dural enhancement in 2 patients, imaging features remained unchanged over a median follow-up of 13 months (range 5-49 months).
Functional imaging. Of the 5 (patients 1, 2, 4, 5, and 7) who had PET or SPECT, relative hypometabolism of the frontal or temporal lobes was noted (table 2, figure 2).
CT myelogram/cisternography. All except patient 5 had a myelogram or cisternogram. A site of CSF leak was found in only one (patient 8), though nerve root sleeve diverticula or early bladder activity was commonly noted (table 2) .
Treatments and outcomes. Over a median follow-up of 11 months (range 4 months-4 years), all patients demonstrated slow, mild progression of their behavioral and cognitive symptoms, as reported by caregivers. Four patients underwent medical or surgical therapy directed at treatment of CSF leaks. Patient 2 was given a short course of IV methylprednisolone, without benefit. He died 4 months later of a myocardial infarction.
Over 5 years, patient 6 had 2 courses of IV methylprednisolone and 5 thoracic or lumbar epidural blood patches. With each treatment, he improved in spontaneity for 1 week to 1 month. After one treatment, he maintained improvement for 3 years before his symptoms returned after an acute headache with exercise. Abbreviation: FBSS ϭ frontotemporal brain sagging syndrome. a Enhancement resolved or less intense on subsequent imaging.
Patient 7 had 2 lumbar epidural blood patches with transient improvement lasting a few days. Oral prednisone for 6 months was not beneficial.
Patient 8 had repair of a lumbar CSF leak. Following surgery, the choreiform movements, cognitive function, and spontaneity improved. However, 2 months later, she declined to her previous level of functioning. Repeat imaging was unchanged and a lumbar epidural blood patch was not beneficial.
Neuropathologic findings. Two patients had detailed neuropathologic examinations. At autopsy, patient 2's brain showed mild generalized atrophy with moderate diffuse senile plaques of the neocortex and sparse neurofibrillary tangles of the medial temporal lobe structures. Patient 6 had a right frontal lobe bi-opsy with nonspecific gliosis and microglial activation noted. There were no intraneuronal inclusions immunoreactive to ubiquitin, tau, or TDP-43 in either case. DISCUSSION We describe 8 patients with clinical and functional imaging features mimicking bvFTD. 1, 2, 6, 7 However, these patients also displayed clinical features somewhat atypical for bvFTD, as well as MRI features of brain sag.
The age at onset and male predominance in our patients with FBSS is typical of bvFTD. 8 However, our patients with FBSS also had daytime somnolence and headache, and some had dysarthria, dysphagia, gait disturbance, ocular abnormalities, or movement disorders. These are not typical features of bvFTD, although some do occur in FTD with motor neuron disease, familial FTD, and extrapyramidal syndromes. 4 Furthermore, patients with FBSS do not show frontotemporal atrophy commonly seen in bvFTD, although they do show frontotemporal hypometabolism. 2 Lack of atrophy is rare, although it has been described, in pathologically confirmed frontotemporal lobar degeneration (FTLD). 9 However, neuropathologic examination, when available, did not demonstrate histopathologic changes consistent with FTLD. 2, 4, 5, 8 The lack of typical MRI or pathologic findings suggests a different etiology of the clinical bvFTDlike phenotype in FBSS. The sagging brain likely leads to mechanical forces on frontotemporal structures or their circuits. Decreased salient network connectivity within the cortices, deep midline, and brainstem structures with enhanced cortical default mode network connectivity has been associated with bvFTD. 10 The marked distortion of the deep midline and brainstem structures in FBSS may disrupt these networks in a similar pattern. In addition, disruption of the cerebellar networks modulating inputs to the frontotemporal circuits may also be playing a role. 11 The sagging brain in FBSS may be due to a CSF leak or spontaneous intracranial hypotension, where brain sag is also a common imaging finding. [12] [13] [14] [15] [16] In fact, CSF leaks have been previously implicated in the presentations of FTD [17] [18] [19] and in patients with deep brain swelling with few neurologic symptoms and scarce pachymeningeal enhancement. 20 However, patients with FBSS often lacked the most common clinical and imaging manifestations of CSF leaks: orthostatic headache 16, 21 and pachymeningeal enhancement. 13, 22, 23 Furthermore, CSF hypotension and a definite leak was found in only one patient, and no patient had complete response to therapy directed at a leak. Nevertheless, a variety of presentations of CSF leaks are becoming increasingly recognized [17] [18] [19] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] : pachymeningeal enhancement can be absent, opening pressure can be normal in a significant minority, [34] [35] [36] CT myelography may only show meningeal diverticula as leaks can be difficult to visualize, 22 early bladder activity on cisternography occurs in high frequency in active leaks, 22, 37, 38 and lack of sustained improvement with epidural blood patch is not uncommon. 22, 37 Thus, the brain sagging in FBSS likely is due to an unrecognized CSF leak, but we cannot exclude other, as yet, unidentified etiology.
Our study has several limitations. There is a lack of consistent neuropsychological data and sufficient follow-up to demonstrate clinical and imaging progression. Resolution of the brain sag and frontotem-poral hypometabolism after treatment for a CSF leak would be helpful to demonstrate pathogenicity of the leaks.
We have identified a group of patients presenting with insidious and progressive behavior and cognitive changes mimicking bvFTD. However, the marked brain sagging likely reflects an etiology different from that causing typical bvFTD. We have termed this FBSS. It is important to recognize FBSS since this is a potentially reversible syndrome. 
